Skip to main content
Erschienen in: Diabetologia 3/2011

01.03.2011 | Article

Cancer in patients admitted to hospital with diabetes mellitus aged 30 years and over: record linkage studies

verfasst von: C. J. Wotton, D. G. R. Yeates, M. J. Goldacre

Erschienen in: Diabetologia | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The aim of this study was to determine the risk of cancer in people admitted to hospital for diabetes mellitus when aged 30 or older.

Methods

This study involved the analysis of two statistical datasets of linked hospital and mortality data, in an area in southern England, between 1963 and 1998 (the Oxford Record Linkage Study, ORLS1) and between 1999 and 2008 (ORLS2). Rates of cancer in the diabetes cohorts were compared with rates of cancer in reference cohorts and expressed as rate ratios.

Results

The rate ratio for all cancer in people admitted to hospital with diabetes was 1.01 (95% CI 0.95–1.06, based on 15,898 people with diabetes) for the years 1963–1998; and 1.09 (1.00–1.19, based on 7,771 people with diabetes) in the years 1999–2008. In both datasets, there were significantly high rate ratios for cancers of the liver (ORLS1 and ORLS2, respectively, 2.0 [95% CI 1.4–2.9]; 2.5 [95% CI 1.3–4.3]), pancreas (2.2 [95% CI 1.8–2.7]; 3.5 [95% CI 2.5–4.8]) and uterus (1.5 [95% CI 1.0–2.2]; 2.6 [95% CI 1.4–4.5]). There were significantly low rate ratios for cancer of the prostate (0.6 [95% CI 0.5–0.7]; 0.7 [95% CI 0.5–0.9]) and non-melanoma skin cancer (0.6 [95% CI 0.5–0.8]; 0.8 [95% CI 0.6–0.96]).

Conclusions/interpretation

Diabetes mellitus was associated with an elevated risk of some site-specific cancers and a reduction of risk of others. Considering the risk in diabetes of all cancers combined, the elevation of risk, if any, is likely to be small and numerically less important than other known complications of diabetes.
Literatur
1.
Zurück zum Zitat Everhart J, Wright D (1995) Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 273:1605–1609CrossRefPubMed Everhart J, Wright D (1995) Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 273:1605–1609CrossRefPubMed
2.
Zurück zum Zitat Huxley R, Ansary-Moghaddam A, Berrington de González A, Barzi F, Woodward M (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92:2076–2083CrossRefPubMed Huxley R, Ansary-Moghaddam A, Berrington de González A, Barzi F, Woodward M (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92:2076–2083CrossRefPubMed
3.
Zurück zum Zitat Hemminki K, Li X, Sundquist J, Sundquist K (2010) Risk of cancer following hospitalization for type 2 diabetes. Oncologist 15:548–555CrossRefPubMed Hemminki K, Li X, Sundquist J, Sundquist K (2010) Risk of cancer following hospitalization for type 2 diabetes. Oncologist 15:548–555CrossRefPubMed
4.
Zurück zum Zitat Larsson SC, Orsini N, Wolk A (2005) Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97:1679–1687CrossRefPubMed Larsson SC, Orsini N, Wolk A (2005) Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97:1679–1687CrossRefPubMed
5.
Zurück zum Zitat Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121:856–862CrossRefPubMed Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121:856–862CrossRefPubMed
6.
Zurück zum Zitat Kaspar JS, Giovannucci E (2006) A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomark Prev 15:2056–2062CrossRef Kaspar JS, Giovannucci E (2006) A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomark Prev 15:2056–2062CrossRef
7.
Zurück zum Zitat Friberg E, Orsini N, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 50:1365–1374CrossRefPubMed Friberg E, Orsini N, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 50:1365–1374CrossRefPubMed
8.
Zurück zum Zitat Larsson SC, Orsini N, Brismar K, Wolk A (2006) Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia 49:2819–2823CrossRefPubMed Larsson SC, Orsini N, Brismar K, Wolk A (2006) Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia 49:2819–2823CrossRefPubMed
9.
Zurück zum Zitat Chao C, Page JH (2008) Type 2 diabetes mellitus and risk of non-Hodgkin lymphoma: a systematic review and meta-analysis. Am J Epidemiol 168:471–480CrossRefPubMed Chao C, Page JH (2008) Type 2 diabetes mellitus and risk of non-Hodgkin lymphoma: a systematic review and meta-analysis. Am J Epidemiol 168:471–480CrossRefPubMed
10.
Zurück zum Zitat Wideroff L, Gridley G, Mellemkjaer L et al (1997) Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89:1360–1365CrossRefPubMed Wideroff L, Gridley G, Mellemkjaer L et al (1997) Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89:1360–1365CrossRefPubMed
11.
Zurück zum Zitat Adami HO, Chow WH, Nyrén O et al (1996) Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 88:1472–1477CrossRefPubMed Adami HO, Chow WH, Nyrén O et al (1996) Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 88:1472–1477CrossRefPubMed
12.
Zurück zum Zitat Libby G, Donnelly LA, Donnan PT, Alessi DR, Morris AD, Evans JMM (2009) New users of metformin are at low risk of incident cancer. A cohort study among people with type 2 diabetes. Diab Care 32:1620–1625CrossRef Libby G, Donnelly LA, Donnan PT, Alessi DR, Morris AD, Evans JMM (2009) New users of metformin are at low risk of incident cancer. A cohort study among people with type 2 diabetes. Diab Care 32:1620–1625CrossRef
13.
Zurück zum Zitat Dejgaard A, Lynggaard H, Råstam J, Krogsgaard Thomsen M (2009) No evidence of increased risk of malignancies in patients with diabetes treated with insulin determir: a meta-analysis. Diabetologia 52:2507–2512CrossRefPubMed Dejgaard A, Lynggaard H, Råstam J, Krogsgaard Thomsen M (2009) No evidence of increased risk of malignancies in patients with diabetes treated with insulin determir: a meta-analysis. Diabetologia 52:2507–2512CrossRefPubMed
14.
Zurück zum Zitat Colhoun HM, SDRN Epidemiology Group (2009) Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 52:1755–1765, Erratum 52: 2469CrossRefPubMed Colhoun HM, SDRN Epidemiology Group (2009) Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 52:1755–1765, Erratum 52: 2469CrossRefPubMed
15.
Zurück zum Zitat Bowker SL, Majumdar SR, Veugelers P, Johnson JA (2006) Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diab Care 29:254–258CrossRef Bowker SL, Majumdar SR, Veugelers P, Johnson JA (2006) Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diab Care 29:254–258CrossRef
16.
Zurück zum Zitat Goldacre M, Kurina L, Yeates D, Seagroatt V, Gill L (2000) Use of a large medical database to study associations between diseases. QJM 93:669–675CrossRefPubMed Goldacre M, Kurina L, Yeates D, Seagroatt V, Gill L (2000) Use of a large medical database to study associations between diseases. QJM 93:669–675CrossRefPubMed
17.
Zurück zum Zitat Fois AF, Wotton CJ, Yeates D, Turner MR, Goldacre MJ (2010) Cancer in patients with motor neuron disease, multiple sclerosis, and Parkinson’s disease: record linkage studies. J Neurol Neurosurg Psychiatry 81:215–221CrossRefPubMed Fois AF, Wotton CJ, Yeates D, Turner MR, Goldacre MJ (2010) Cancer in patients with motor neuron disease, multiple sclerosis, and Parkinson’s disease: record linkage studies. J Neurol Neurosurg Psychiatry 81:215–221CrossRefPubMed
18.
Zurück zum Zitat Goldacre MJ, Kurina LM, Wotton CJ, Yeates D, Seagroatt V (2005) Schizophrenia and cancer: an epidemiological study. Br J Psych 187:334–338CrossRef Goldacre MJ, Kurina LM, Wotton CJ, Yeates D, Seagroatt V (2005) Schizophrenia and cancer: an epidemiological study. Br J Psych 187:334–338CrossRef
19.
Zurück zum Zitat Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D (2005) Cancer following hip and knee arthroplasty: record linkage study. Br J Cancer 92:1298–1301CrossRefPubMed Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D (2005) Cancer following hip and knee arthroplasty: record linkage study. Br J Cancer 92:1298–1301CrossRefPubMed
20.
Zurück zum Zitat Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D (2006) Cancer and cardiovascular disease after vasectomy: an epidemiological database study. Fertil Steril 84:1438–1443CrossRef Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D (2006) Cancer and cardiovascular disease after vasectomy: an epidemiological database study. Fertil Steril 84:1438–1443CrossRef
21.
Zurück zum Zitat Goldacre MJ, Wotton CJ, Yeates D, Seagroatt V, Jewell D (2008) Cancer in patients with ulcerative colitis, Crohn’s disease and coeliac disease: record linkage study. Eur J Gastroenterol 20:297–304CrossRef Goldacre MJ, Wotton CJ, Yeates D, Seagroatt V, Jewell D (2008) Cancer in patients with ulcerative colitis, Crohn’s disease and coeliac disease: record linkage study. Eur J Gastroenterol 20:297–304CrossRef
22.
Zurück zum Zitat Goldacre MJ, Wotton CJ, Yeates D, Seagroatt V, Collier J (2008) Liver cirrhosis, other liver disease, pancreatitis and subsequent cancer: record linkage study. Eur J Gastroenterol 20:384–392CrossRef Goldacre MJ, Wotton CJ, Yeates D, Seagroatt V, Collier J (2008) Liver cirrhosis, other liver disease, pancreatitis and subsequent cancer: record linkage study. Eur J Gastroenterol 20:384–392CrossRef
24.
Zurück zum Zitat Breslow NE, Day NE (1987) Statistical methods in cancer research, Volume II. The design and analysis of cohort studies. IARC scientific publication No. 82. International Agency for Research in Cancer, Lyon, pp 103–115 Breslow NE, Day NE (1987) Statistical methods in cancer research, Volume II. The design and analysis of cohort studies. IARC scientific publication No. 82. International Agency for Research in Cancer, Lyon, pp 103–115
25.
Zurück zum Zitat Ogunleye AA, Ogston SA, Morris AD, Evans JMM (2009) A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer 101:1199–1201CrossRefPubMed Ogunleye AA, Ogston SA, Morris AD, Evans JMM (2009) A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer 101:1199–1201CrossRefPubMed
26.
Zurück zum Zitat Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D et al (1991) Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2:307–314CrossRefPubMed Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D et al (1991) Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2:307–314CrossRefPubMed
28.
Zurück zum Zitat Hernández-Díaz S, Adami H-O (2010) Diabetes therapy and cancer risk: causal effects and other plausible explanations. Diabetologia 53:802–808CrossRefPubMed Hernández-Díaz S, Adami H-O (2010) Diabetes therapy and cancer risk: causal effects and other plausible explanations. Diabetologia 53:802–808CrossRefPubMed
30.
Zurück zum Zitat La Vecchia C, Negri E, Franceschi S, D’Avanzo B, Boyle P (1994) A case–control study of diabetes mellitus and cancer risk. Br J Cancer 70:950–953CrossRefPubMed La Vecchia C, Negri E, Franceschi S, D’Avanzo B, Boyle P (1994) A case–control study of diabetes mellitus and cancer risk. Br J Cancer 70:950–953CrossRefPubMed
31.
Zurück zum Zitat Silverman DT, Schiffman M, Everhart J et al (1999) Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 80:1830–1837CrossRefPubMed Silverman DT, Schiffman M, Everhart J et al (1999) Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 80:1830–1837CrossRefPubMed
32.
Zurück zum Zitat Friberg E, Mantzoros CS, Wolk A (2007) Diabetes and risk of endometrial cancer: a population-based prospective cohort study. Cancer Epidemiol Biomark Prev 16:276–280CrossRef Friberg E, Mantzoros CS, Wolk A (2007) Diabetes and risk of endometrial cancer: a population-based prospective cohort study. Cancer Epidemiol Biomark Prev 16:276–280CrossRef
33.
Zurück zum Zitat Moss SF, Blaser MJ (2005) Mechanisms of disease: inflammation and the origins of cancer. Nat Clin Pract Oncol 2:90–97CrossRefPubMed Moss SF, Blaser MJ (2005) Mechanisms of disease: inflammation and the origins of cancer. Nat Clin Pract Oncol 2:90–97CrossRefPubMed
34.
Zurück zum Zitat Crook M (2003) Type 2 diabetes mellitus: a disease of the innate immune system? An update. Diabet Med 21:203–207CrossRef Crook M (2003) Type 2 diabetes mellitus: a disease of the innate immune system? An update. Diabet Med 21:203–207CrossRef
35.
Zurück zum Zitat Chuang T-Y, Lewis DA, Spandau DF (2005) Decreased incidence of nonmelanoma skin cancer in patients with type 2 diabetes mellitus using insulin: a pilot study. Br J Dermatol 153:552–557CrossRefPubMed Chuang T-Y, Lewis DA, Spandau DF (2005) Decreased incidence of nonmelanoma skin cancer in patients with type 2 diabetes mellitus using insulin: a pilot study. Br J Dermatol 153:552–557CrossRefPubMed
36.
Zurück zum Zitat Alpert PT, Shaikh U (2007) The effects of vitamin D deficiency and insufficiency on the endocrine and paracrine systems. Biol Res Nurs 9:117–129CrossRefPubMed Alpert PT, Shaikh U (2007) The effects of vitamin D deficiency and insufficiency on the endocrine and paracrine systems. Biol Res Nurs 9:117–129CrossRefPubMed
Metadaten
Titel
Cancer in patients admitted to hospital with diabetes mellitus aged 30 years and over: record linkage studies
verfasst von
C. J. Wotton
D. G. R. Yeates
M. J. Goldacre
Publikationsdatum
01.03.2011
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 3/2011
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-010-1987-2

Weitere Artikel der Ausgabe 3/2011

Diabetologia 3/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.